홈MCP워크벤치Skills
홈워크벤치알림마이페이지
Huagongshe 오픈 프로젝트:[email protected]AI 접속: llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.7.8
  1. 홈
  2. /화합물

Trifluoperazine

HCID 5566
노트반응
기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
부분 구조 검색유사 구조 찾기

기본 정보

CAS
117-89-5
표준 SMILES
CN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1
InChIKey
ZEWQUBUPAILYHI-UHFFFAOYSA-N
분자식
C21H24F3N3S
평균 분자량
407.5 g/mol
단동위원소 질량
407.16430344

개요

Trifluoperazine is a member of the class of phenothiazines that is phenothiazine having a trifluoromethyl subsitituent at the 2-position and a 3-(4-methylpiperazin-1-yl)propyl group at the N-10 position. It has a role as a calmodulin antagonist, a phenothiazine antipsychotic drug, a dopaminergic antagonist, an antiemetic, an EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor and an EC 5.3.3.5 (cholestenol Delta-isomerase) inhibitor. It is an organofluorine compound, a member of phenothiazines, a N-alkylpiperazine and a N-methylpiperazine.

이름 및 식별자

우선 이름
Trifluoperazine
IUPAC
10-[3-(4-methylpiperazin-1-yl)propyl]-2-(trifluoromethyl)phenothiazine
영어명
Trifluoperazine
분자식
C21H24F3N3S
분자량
407.5

이름 및 동의어

trifluoperazine117-89-5TrifluperazineTrifluoroperazineTrifluoperazinTriperazineTrifluoperazinaFlurazineTriflurinTrifluoromethylperazineTrifluoperazinum10-[3-(4-methylpiperazin-1-yl)propyl]-2-(trifluoromethyl)phenothiazine
이름 더 보기
Triphthazinerp7623Stellazine
Apo-TrifluoperazineTriftazinRP 7623EskazinylModalinaTrifluoromethyl-10-(3'-(1-methyl-4-piperazinyl)propyl)phenothiazine10-[3-(4-methylpiperazin-1-yl)propyl]-2-(trifluoromethyl)-10H-phenothiazine10H-Phenothiazine, 10-[3-(4-methyl-1-piperazinyl)propyl]-2-(trifluoromethyl)-

데이터베이스 식별자

CAS
117-89-5
PubChem CID
5566
DTXSID
DTXSID1046928
ChEMBL
CHEMBL422
ChEBI
CHEBI:45951
UNII
214IZI85K3
EC Number
204-219-4
Nikkaji
J5.293K

물성

구조 계산 물성

XLogP
5
극성 표면적
35 Ų
수소 결합 공여자 수
0
수소 결합 수용자 수
7
회전 가능 결합 수
4
무거운 원자 수
28
형식 전하
0
복잡도
510

실험 및 물리화학적 성질

Drugs · 4건

DEA NFLIS-Drug Category -> Depressants and Tranquilizers

Pharmaceuticals -> Nervous system -> Antipsychotics

Pharmaceuticals -> Listed in ZINC15

Pharmaceuticals -> Antipsychotics

LogP · 3건

log Kow= 5.03 @ 25 °C

4.9

4.71

Solubility · 4건

Freely sol in water /Dihydrochloride/

FREELY SOL IN WATER; SOL IN ALCOHOL; SPARINGLY SOL IN CHLOROFORM; INSOL IN ETHER & BENZENE /HYDROCHLORIDE/

In water, 12.2 mg/l @ 25 °C

8.76e-03 g/L

Human Drugs · 2건

Breast Feeding; Lactation; Milk, Human; Antipsychotic Agents; Phenothiazines

Pharmaceuticals

Boiling Point202-210 °C @ 0.6 mm Hg
DecompositionWhen heated to decomposition it emits very toxic fumes of /hydrogen fluoride/, nitroxides, and sulfoxides.
Melting Point · 3건

Cream-colored, fine powder from absolute alcohol; MP: 242-243 °C; pH of 5% aq soln= 2.2, Hygroscopic /Dihydrochloride/

MP: 193-194 °C; crystals from alcohol /Dimaleate/

MP: 173-175 °C /Sulfoxide dihydrochloride trihydrate/

안전 및 규제

안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.

유해성 정보

FDA Requirements · 1건

Manufacturers, packers, and distributors of drug and drug products for human use are responsible for complying with the labeling, certification, and usage requirements as prescribed by the Federal Food, Drug, and Cosmetic Act, as amended (secs 201-902, 52 Stat. 1040 et seq., as amended; 21 U.S.C. 321-392).

안전 및 보호

Storage ConditionsTrifluoperazine HCl should be stored at controlled room temperature and protected from light and freezing. Exposure to light may result in discoloration. /Trifluoperazine HCl/
Disposal Methods · 1건

SRP: At the time of review, criteria for land treatment or burial (sanitary landfill) disposal practices are subject to significant revision. Prior to implementing land disposal of waste residue (including waste sludge), consult with environmental regulatory agencies for guidance on acceptable disposal practices.

독성 정보

Treatment · 1건

Treatment is essentially symptomatic and supportive. Early gastric lavage is helpful. Keep patient under observation and maintain an open airway, since involvement of the extrapyramidal mechanism may produce dysphagia and respiratory difficulty in severe overdosage. Do not attempt to induce emesis because a dystonic reaction of the head or neck may develop that could result in aspiration of vomitus. Extrapyramidal symptoms may be treated with anti-parkinsonism drugs, barbiturates or Benadryl. See prescribing information for these products. Care should be taken to avoid increasing respiratory depression. If administration of a stimulant is desirable, amphetamine, dextroamphetamine or caffeine with sodium benzoate is recommended. Stimulants that may cause convulsions (e.g., picrotoxin or pentylenetetrazol) should be avoided. If hypotension occurs, the standard measures for managing circulatory shock should be initiated. If it is desirable to administer a vasoconstrictor, Levophed and Neo-Synephrine are most suitable. Other pressor agents, including epinephrine, are not recommended because phenothiazine derivatives may reverse the usual elevating action of these agents and cause a further lowering of blood pressure. (L1712)

화학 및 산업

약리 정보

ATC Code · 2건

N - Nervous system

QN - Nervous system

Pharmacodynamics · 1건

Trifluoperazine is a trifluoro-methyl phenothiazine derivative intended for the management of schizophrenia and other psychotic disorders. Trifluoperazine has not been shown effective in the management of behaviorial complications in patients with mental retardation.

Mechanism of Action · 2건

Trifluoperazine blocks postsynaptic mesolimbic dopaminergic D1 and D2 receptors in the brain; depresses the release of hypothalamic and hypophyseal hormones and is believed to depress the reticular activating system thus affecting basal metabolism, body temperature, wakefulness, vasomotor tone, and emesis.

...PHENOTHIAZINES, BLOCK DOPAMINE RECEPTORS & INCR TURNOVER RATE OF DOPAMINE IN CORPUS STRIATUM. INCR TURNOVER RATE IS BELIEVED TO BE RESULT OF NEURONAL FEEDBACK MECHANISM. ...OF IDENTIFIED DOPAMINERGIC NEURONS IN SUBSTANTIA NIGRA & VENTRAL TEGMENTAL AREAS. SPONTANEOUS FIRING OF THESE CELLS IS INCR... /PHENOTHIAZINES/

Biological Half-Life10-20 hours
Metabolism/Metabolites · 4건

Hepatic.

AFTER CHRONIC ADMIN OF PIPERAZINE-SUBSTITUTED PHENOTHIAZINE DRUGS...TO RATS, TISSUES CONTAINED DRUG METABOLITES, IN WHICH PIPERAZINE RING FISSION BY MULTIPLE OXIDATIVE N-DEALKYLATION HAD OCCURRED TO GIVE SUBSTITUTED ETHYLENEDIAMINE. ...2-TRIFLUOROMETHYL ANALOGUE WAS FORMED SIMILARLY FROM TRIFLUPERAZINE.

IN VIVO DEGRADATION OF PIPERAZINE RING OF TRIFLUOPERAZINE LEADS TO FORMATION OF GAMMA-(PHENOTHIAZINYL-10)-PROPYLAMINE & ITS RING SUBSTITUTED ANALOGS CF3- & CL-. SULFOXIDES OF THESE METABOLITES HAVE BEEN IDENTIFIED AS URINARY BIOTRANSFORMATION PRODUCTS IN RATS (CHRONIC).

Hepatic. Half Life: 10-20 hours

FDA Pharmacological Classification · 5건

214IZI85K3

TRIFLUOPERAZINE

Established Pharmacologic Class [EPC] - Phenothiazine

Chemical Structure [CS] - Phenothiazines

Trifluoperazine is a Phenothiazine.

관련 반응

0건
반응 기록 만들기

현재 필터 조건에 해당하는 반응 기록이 없습니다.

화합물 노트

불러오는 중…

이 페이지에서기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
Physical Description
Solid
Stability/Shelf LifeIn aqueous solution, trifluoperazine HCl is readily oxidized by atmospheric oxygen. /Trifluoperazine HCl/
Dissociation ConstantspKa1= 3.9; pKa2= 8.1 /Dihydrochloride/
Collision Cross Section · 2건

188.1 Ų [M+H]+ [CCS Type: TW; Method: Major Mix IMS/Tof Calibration Kit (Waters)]

191.59 Ų [M+Na]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

Other Experimental PropertiesPRACTICALLY ODORLESS & HAS BITTER TASTE; MELTS @ ABOUT 242 °C WITH DECOMP WHITE TO PALE-YELLOW, CRYSTALLINE POWDER /HYDROCHLORIDE/

물리화학적 성질

녹는점
232 °C · 232°C
끓는 점
0.6 · bp0.6 202-210°
밀도
1.206 · 1.2060 (estimate)
저장 조건
-20 °C · Hygroscopic, -20°C Freezer, Under inert atmosphere
용해도
DMSO(약간 용해됨), 메탄올(약간 용해됨), 물(약간 용해됨)
물리적 상태
고체
산도 계수 (pKa)
8.05 · pKa 8.05±0.04(H2O t = 20 0.5 I not reported but pKa was stated to be independent of I.) (Uncertain)
색상
흰색에서 황백색까지
수용성
12.23 mg/L · 12.23mg/L(24℃)
NIST
Trifluoperazine(117-89-5)
Interactions · 5건

Additive QT interval prolongation may increase the risk of ventricular tachycardia when /probucol is used with phenothiazines/. /Phenothiazines/

Concurrent use /of other photosensitizing medications/ with phenothiazines may cause additive photosensitizing effects. In addition, concurrent use of systemic methoxsalen, trixsalen, or tetracyclines with phenothiazines may potentiate intraocular photochemical damage to the choroid, retina, or lens. /Phenothiazines/

Prior administration of phenothiazines may decrease the pressor effect and shorten the duration of action of phenylephrine. /Phenothiazines/

In addition to increased CNS and respiratory depression, concurrent use /of opiod (narcotic) analgesics/ with phenothiazines increases orthostatic hypotension and increases the risk of severe constipation, which may lead to paralytic ileus, and/or urinary retention. /Phenothiazines/

For more Interactions (Complete) data for TRIFLUOPERAZINE (29 total), please visit the HSDB record page.

Hepatotoxicity · 1건

Liver test abnormalities have been reported to occur in a high proportion of patients on long term phenothiazine therapy, but elevations are uncommonly above 3 times the upper limit of normal. The aminotransferase abnormalities are usually mild, asymptomatic and transient, reversing even with continuation of medication. Rare instances of clinically apparent acute liver injury, resembling that due to chlorpromazine, have been reported with trifluoperazine therapy. The onset of jaundice is usually within 1 to 4 weeks, and the pattern of serum enzyme elevations is typically cholestatic or mixed. Immunoallergic features (rash, fever and eosinophilia) were present in some cases but were mild and self-limited; autoantibodies were rare.

Exposure RoutesOral
Milk ConcentrationsPHENOTHIAZINES ... MAY APPEAR IN MILK OF NURSING MOTHERS... /PHENOTHIAZINES, HUMAN, ORAL, IM/
Toxicity Summary · 1건

Trifluoperazine blocks postsynaptic mesolimbic dopaminergic D1 and D2 receptors in the brain; depresses the release of hypothalamic and hypophyseal hormones and is believed to depress the reticular activating system thus affecting basal metabolism, body temperature, wakefulness, vasomotor tone, and emesis.

Signs and SymptomsSymptoms of overdose include agitation, coma, convulsions, difficulty breathing, difficulty swallowing, dry mouth, extreme sleepiness, fever, intestinal blockage, irregular heart rate, low blood pressure, and restlessness.
Human Toxicity Excerpts · 5건

EPITHELIAL KERATOPATHY OFTEN IS OBSERVED IN PATIENTS ON LONG-TERM THERAPY WITH CHLORPROMAZINE, AND OPACITIES IN THE CORNEA AND IN THE LENS OF THE EYE ALSO HAVE BEEN NOTED. ... PIGMENTARY RETINOPATHY HAS BEEN REPORTED, PARTICULARLY FOLLOWING DOSES OF THIORIDAZINE IN EXCESS OF 1000 MG/DAY; A MAXIMUM DAILY DOSE OF 800 MG CURRENTLY IS RECOMMENDED. /PHENOTHIAZINES/

...OCULOGYRIC CRISES CAN BE PRODUCED... BLURRING OF VISION HAS BEEN MENTIONED OCCASIONALLY, ASSOC WITH DRYNESS OF MOUTH, WHICH SUGGESTS THAT BLURRING MIGHT BE DUE TO ANTICHOLINERGIC MYDRIASIS & CYCLOPLEGIA. ...SUSPICIONS...THAT TRIFLUOPERAZINE PRODUCES DEPOSITS IN LENS OR CORNEA.

LARGE DOSES (80 MG TRIFLUOPERAZINE) ARE MORE LIKELY TO PRODUCE OR AGGRAVATE DYSKINESIA IN PT AGE 40-55 THAN ARE CONVENTIONAL DOSES. RISK OF PERSISTENT MOTOR ABNORMALITIES RISES SHARPLY IN OLDER PERSONS WITH CHRONIC DOSING OF 100-200 MG CHLORPROMAZINE OR EQUIV.

Most studies indicate the phenothiazines are nonteratogenic but there are reports of defects in infants exposed to these drugs during the first trimester. /Phenothiazines/

For more Human Toxicity Excerpts (Complete) data for TRIFLUOPERAZINE (7 total), please visit the HSDB record page.

Carcinogen ClassificationNo indication of carcinogenicity to humans (not listed by IARC).
Drug Induced Liver Injury · 6건

Benchmark Dataset for the Liver Toxicity Knowledge Base (LTKB)

trifluoperazine

Stelazine

Antipsychotics

2

less-DILI-concern drugs

Populations at Special Risk · 1건

... TRIFLUOPERAZINE HAS A HIGH TENDENCY TO PRODUCE EXTRAPYRAMIDAL EFFECTS ... EXTRAPYRAMIDAL SYMPTOMS PRESENTING AS TORTICOLLIS, STIFFENING OF THE BODY, SPASTICITY, IMPAIRED SPEECH, AND OPISTHOTONOS MAY OCCUR. THESE SYMPTOMS MAY OCCUR FREQUENTLY IN CHILDREN WHO HAVE BEEN ADMINISTERED PROCHLORPERAZINE (cOMPAZINE) FOR THE TREATMENT OF NAUSEA AND VOMITING. /PHENOTHIAZINES/

Antidote and Emergency Treatment · 1건

EXTRAPYRAMIDAL SYMPTOMS...RELIEVED WITH BARBITURATES, METHYLPHENIDATE HYDROCHLORIDE...ANTI-PARKINSON DRUGS...BENZTROPINE MESYLATE...TRIHEXYPHENIDYL HYDROCHLORIDE...DIPHENHYDRAMINE HYDROCHLORIDE...IN SEVERE CASES, SUPPORTIVE THERAPY...MAINTAINING CLEAR AIRWAY & ADEQUATE HYDRATION. /HYDROCHLORIDE/

규제 정보

FDA Requirements · 1건

Manufacturers, packers, and distributors of drug and drug products for human use are responsible for complying with the labeling, certification, and usage requirements as prescribed by the Federal Food, Drug, and Cosmetic Act, as amended (secs 201-902, 52 Stat. 1040 et seq., as amended; 21 U.S.C. 321-392).

안전 데이터

독성
LD50 orally in rats, mice: 542.7, 424.0 mg/ml (Fowler)
유해 물질 데이터
117-89-5(Hazardous Substances Data)
MeSH Pharmacological Classification · 3건

Drugs used to prevent NAUSEA or VOMITING.

Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus.

Drugs that bind to but do not activate DOPAMINE RECEPTORS, thereby blocking the actions of dopamine or exogenous agonists. Many drugs used in the treatment of psychotic disorders (ANTIPSYCHOTIC AGENTS) are dopamine antagonists, although their therapeutic effects may be due to long-term adjustments of the brain rather than to the acute effects of blocking dopamine receptors. Dopamine antagonists have been used for several other clinical purposes including as ANTIEMETICS, in the treatment of Tourette syndrome, and for hiccup. Dopamine receptor blockade is associated with NEUROLEPTIC MALIGNANT SYNDROME.

Absorption, Distribution and ExcretionULTIMATE SOJOURN OF PHENOTHIAZINE DRUGS IN BODY IS EXCEEDINGLY LONG. /PHENOTHIAZINES/
Cellular LocationsCytoplasm

용도 및 제조

Uses · 2건

Antipsychotic

For the treatment of anxiety disorders, depressive symptoms secondary to anxiety and agitation.

Methods of ManufacturingCraig et al, J Org Chem 22, 709 (1957); British patents 813,861 & 829,246 (1959 & 1960 to SK & F).
Formulations/Preparations · 2건

TABLET: 1, 2, 5, 10 MG; CAPSULE: 10 MG/ML; VIAL: 2 MG/ML IN 10 ML. /FROM TABLE, HYDROCHLORIDE/

SYRUP NF: 10 MG/ML /HYDROCHLORIDE/

Use ClassificationPharmaceuticals
General Manufacturing Information · 2건

THE NATURE OF SUBSTITUENT @ POSITION 10 ALSO INFLUENCES PHARMACOLOGICAL ACTIVITY. ... SEVERAL POTENT PHENOTHIAZINE ANTIPSYCHOTIC COMPOUNDS HAVE A PIPERAZINE (OR PIPERAZINYL) GROUP IN THE SIDE CHAIN; ... TRIFLUOPERAZINE /IS AN/ EXAMPLE.

Phenothiazine has a three-ring structure in which two benzene rings are linked by a sulfur and a nitrogen atom. If the nitrogen at position 10 is replaced by a carbon atom with a double bond to the side chain, the compound is a thioxanthene. /PHENOTHIAZINES/

응용 분야 · 1건

용도Trifluoperazine is one of the most active antipsychotic drugs. A moderate stimulatory effect accompanies the neuroleptic effect. Trifluoperazine is unique in that, patients instead of the usual stiffness and weakness characteristic of phenothazine derivatives, become more lively. This drug has a strong anticonvulsant activity. It is widely used in psychiatry for treating schizophrenia and other mental illnesses.

상·하류 제품 정보

상류 원료

나트륨아미드1-(3-클로로프로필)-4-메틸피페라진2-(트리플루오로메틸)페노티아진트리플루오페라진설폭사이드N-메틸피페라진

하류 제품

트리플루오페라진N-β-D-글루쿠로나이드

공급사45 곳

北京华美互利生物化工010-56205725 · [email protected]
Career Henan Chemica Co+86-0371-86658258 +86-13203830695 · [email protected]
成都超九八生物科技有限公司13348960310 13348960310 · [email protected]
上海麦克林生化科技股份有限公司021-50706066 15221275939 · [email protected]
上海毕合生物化学技术有限公司13816464724 15900990114 · [email protected]
Dayang Chem (Hangzhou) Co.,Ltd.+86-0571-88938639 17705817739 · [email protected]
Syntechem Co.,Ltd[email protected]
Allfluoro Pharmaceutical Company Limited+86-400-0216110 +86-15958047586 · [email protected]
United Life Science020-82099279 18988968278 · [email protected]
銳迪國際科技有限公司18024082417 · [email protected]
卡迪亚医药科技有限公司0371-86615086 18203638366 0371-86159066 13526786601
PT CHEM GROUP LIMITED+86-85511178; +86-85511178 · [email protected]
Labnetwork lnc.+86-27-50766799 +86-18062016861 · [email protected]
天津普西唐生物医药科技有限公司010-60605840 · [email protected]
上海寰川实业有限公司021-61478794 · [email protected]
陕西缔都医药化工有限公司029-81024372 17792795018 · [email protected]
青岛海智微元生物科技有限公司18317699790 18317699790 · [email protected]
杭州六可生物科技有限公司+86-0571-86912261 +86-15658003402 · [email protected]
上海陶术生物科技股份有限公司+1-781-999-5354; +1-00000000000 · [email protected]
安耐吉化学&3A(安徽泽升科技股份有限公司)400-0056266 · [email protected]
上海阿拉丁生化科技股份有限公司6206333 13167063860 · [email protected]
上海珞珐生化科技有限公司021-51111890 15317326293 · [email protected]
上海源叶生物科技有限公司18916372613 · [email protected]
上海芮晖化工科技有限公司021-31433387 15618786686 · [email protected]
上海相辉医药科技有限公司[email protected]
Shaanxi Didu New Materials Co. Ltd+86-86-17392712779 +86-13289823923 · [email protected]
杭州洁汉化工有限公司+86-571-86217390; +8618058761490 · [email protected]
河南天孚化工有限公司+86-0371-55170693 +86-19937530512 · [email protected]
ATK CHEMICAL COMPANY LIMITED+undefined-21-51877795 · [email protected]
成都圣美凯生物科技有限公司028-85157043 15882256948 · [email protected]
海蔚化学86-21-51086038 · [email protected]
Hebei Chuanghai Biotechnology Co., Ltd+86-15350571055 · [email protected]
Aladdin Scientific[email protected]
XIAMEN AMITY INDUSTRY AND TRADE CO., LTD.+8618950047208 · [email protected]
山西诺诚生物科技有限公司17835231871 · [email protected]
TargetMol中国(陶术生物)4008200310 15002144251 · [email protected]
重庆卡兰医药有限公司[email protected]
上海相辉医药科技有限公司13611835272 13611835272 · [email protected]
HANGZHOU CLAP TECHNOLOGY CO.,LTD86-571-88216897,88216896 13588875226 · [email protected]
上海智溯科生物科技有限公司021-58056897 15399714481 · [email protected]
上海陶术生物科技股份有限公司+1-781-999-5354 · [email protected]
南京世洲生物科技有限公司025-85560043 15850508050 · [email protected]
南京世洲生物科技有限公司17301488900 · [email protected]
上海阿摩尔生物科技有限公司13370042665 18916960931 · [email protected]
上海安毕达生物科技有限公司021-61629020 18201956406 · [email protected]